A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.
Abou-Alfa GK, Capanu M, O'Reilly EM, Ma J, Chou JF, Gansukh B, Shia J, Kalin M, Katz S, Abad L, Reidy-Lagunes DL, Kelsen DP, Chen HX, Saltz LB.
Abou-Alfa GK, et al.
J Hepatol. 2014 Feb;60(2):319-24. doi: 10.1016/j.jhep.2013.09.008. Epub 2013 Sep 14.
J Hepatol. 2014.
PMID: 24045151
Free PMC article.
Clinical Trial.